Author:
López Lastra Juan Carlos,López Noriega Juan Carlos,Ruiz Rodríguez Rafael,González Reyes Manuel
Reference27 articles.
1. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial surgeons\\\' position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg. 2022; 80 (5): 920-943.
2. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014; 72 (10): 1938-1956.
3. Marx RE. Oral and intravenous bisphosphonateinduced osteonecrosis of the jaws: history, etiology, prevention, and treatment. 2nd edition. 2nd ed. Chicago, IL.: Quintessence; 2019. p. 379.
4. Khan AA, Rios LP, Sándor GK, Khan N, Peters E, Rahman MO et al. Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons. J Rheumatol. 2011; 38 (7): 1396-1402.
5. Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O\\\'Ryan F et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015; 30 (1): 3-23.